Cargando…

Primary peripheral T-cell central nervous system lymphoma

BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, le...

Descripción completa

Detalles Bibliográficos
Autores principales: Bird, Cylaina E., Traylor, Jeffrey I., Thomas, Jenna, Caruso, James P., Kafka, Benjamin, Rosado, Flavia, Blackburn, Kyle M., Hatanpaa, Kimmo J., Abdullah, Kalil G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific Scholar 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492444/
https://www.ncbi.nlm.nih.gov/pubmed/34621580
http://dx.doi.org/10.25259/SNI_224_2021
_version_ 1784578932375289856
author Bird, Cylaina E.
Traylor, Jeffrey I.
Thomas, Jenna
Caruso, James P.
Kafka, Benjamin
Rosado, Flavia
Blackburn, Kyle M.
Hatanpaa, Kimmo J.
Abdullah, Kalil G.
author_facet Bird, Cylaina E.
Traylor, Jeffrey I.
Thomas, Jenna
Caruso, James P.
Kafka, Benjamin
Rosado, Flavia
Blackburn, Kyle M.
Hatanpaa, Kimmo J.
Abdullah, Kalil G.
author_sort Bird, Cylaina E.
collection PubMed
description BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, leading to misdiagnosis and delays in treatment. We present a case of a patient with a history of Sjögren’s syndrome and progressive neurologic symptoms who underwent craniotomy for diagnosis. CASE DESCRIPTION: A 61-year-old woman with a history of Sjögren’s syndrome, progressive aphasia, left facial droop, and right-sided paresthesias for 4 months presented for evaluation and management. An enhancing, infiltrative lesion in the left frontal lobe with underlying vasogenic edema was appreciated and suggestive of a primary or metastatic neoplasm. The patient underwent an open biopsy for further evaluation of the lesion. Extensive histopathologic evaluation revealed a diagnosis of T-cell PCNSL. The patient was started on induction methotrexate and temozolomide followed by consolidative radiotherapy. CONCLUSION: Autoimmune conditions are a risk factor for T-cell PCNSL development. T-cell PCNSL has radiographic and gross histologic features that are consistent with a broad differential, including gliomas and inflammatory processes. Prompt diagnosis and extensive histopathological evaluation is essential to ensure appropriate treatment.
format Online
Article
Text
id pubmed-8492444
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Scientific Scholar
record_format MEDLINE/PubMed
spelling pubmed-84924442021-10-06 Primary peripheral T-cell central nervous system lymphoma Bird, Cylaina E. Traylor, Jeffrey I. Thomas, Jenna Caruso, James P. Kafka, Benjamin Rosado, Flavia Blackburn, Kyle M. Hatanpaa, Kimmo J. Abdullah, Kalil G. Surg Neurol Int Case Report BACKGROUND: Primary peripheral T-cell central nervous system lymphoma (PCNSL) is a rare, aggressive tumor that arises in the craniospinal axis and has an increased risk in individuals who are immunocompromised. This lesion often mimics other benign and malignant processes on radiographic imaging, leading to misdiagnosis and delays in treatment. We present a case of a patient with a history of Sjögren’s syndrome and progressive neurologic symptoms who underwent craniotomy for diagnosis. CASE DESCRIPTION: A 61-year-old woman with a history of Sjögren’s syndrome, progressive aphasia, left facial droop, and right-sided paresthesias for 4 months presented for evaluation and management. An enhancing, infiltrative lesion in the left frontal lobe with underlying vasogenic edema was appreciated and suggestive of a primary or metastatic neoplasm. The patient underwent an open biopsy for further evaluation of the lesion. Extensive histopathologic evaluation revealed a diagnosis of T-cell PCNSL. The patient was started on induction methotrexate and temozolomide followed by consolidative radiotherapy. CONCLUSION: Autoimmune conditions are a risk factor for T-cell PCNSL development. T-cell PCNSL has radiographic and gross histologic features that are consistent with a broad differential, including gliomas and inflammatory processes. Prompt diagnosis and extensive histopathological evaluation is essential to ensure appropriate treatment. Scientific Scholar 2021-09-13 /pmc/articles/PMC8492444/ /pubmed/34621580 http://dx.doi.org/10.25259/SNI_224_2021 Text en Copyright: © 2021 Surgical Neurology International https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Bird, Cylaina E.
Traylor, Jeffrey I.
Thomas, Jenna
Caruso, James P.
Kafka, Benjamin
Rosado, Flavia
Blackburn, Kyle M.
Hatanpaa, Kimmo J.
Abdullah, Kalil G.
Primary peripheral T-cell central nervous system lymphoma
title Primary peripheral T-cell central nervous system lymphoma
title_full Primary peripheral T-cell central nervous system lymphoma
title_fullStr Primary peripheral T-cell central nervous system lymphoma
title_full_unstemmed Primary peripheral T-cell central nervous system lymphoma
title_short Primary peripheral T-cell central nervous system lymphoma
title_sort primary peripheral t-cell central nervous system lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492444/
https://www.ncbi.nlm.nih.gov/pubmed/34621580
http://dx.doi.org/10.25259/SNI_224_2021
work_keys_str_mv AT birdcylainae primaryperipheraltcellcentralnervoussystemlymphoma
AT traylorjeffreyi primaryperipheraltcellcentralnervoussystemlymphoma
AT thomasjenna primaryperipheraltcellcentralnervoussystemlymphoma
AT carusojamesp primaryperipheraltcellcentralnervoussystemlymphoma
AT kafkabenjamin primaryperipheraltcellcentralnervoussystemlymphoma
AT rosadoflavia primaryperipheraltcellcentralnervoussystemlymphoma
AT blackburnkylem primaryperipheraltcellcentralnervoussystemlymphoma
AT hatanpaakimmoj primaryperipheraltcellcentralnervoussystemlymphoma
AT abdullahkalilg primaryperipheraltcellcentralnervoussystemlymphoma